Neoantigen Peptide Vaccine(Fred Hutchinson Cancer Research Center)

新抗原肽疫苗（弗莱德哈钦森癌症研究中心）

Report date: 2022/08/25 14:21:49

Base Information

Drug NameNeoantigen Peptide Vaccine(Fred Hutchinson Cancer Research Center)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSkin MelanomaSolid tumoursHR-positive breast cancer +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesFred Hutchinson Cancer Research Center
China Registration ClassN/A

Develop Information

Active CompaniesFred Hutchinson Cancer Research Center
Inactive CompaniesN/A
Active IndicationsSkin MelanomaSolid tumoursHR-positive breast cancer +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A